Vesalius Biocapital: First Close

VESALIUS Biocapital IV Partners Sarl

Vesalius Biocapital Announces First Close of Fourth Fund Raising EUR 95 Million Significant support from investors including the European Investment Fund Fund to invest in first and best-in-class European life science companies in drug development and digital health Luxembourg-Strassen, 29 June 2023 – Vesalius Biocapital, the specialist life sciences venture capital investor, announces the first […]